Projects per year
A translational framework for discovering novel solutions for drug resistance in acute myeloid leukaemia
1/01/20 → 31/12/24
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination with Reduced-Intensity Chemotherapy, in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL).
Fleming, S. A. & Kennedy, N.